Table 2.

Major demographics of the IHC sample set

TamoxifenPlacebo
Number of patients79100
Age: median (range), y48 (37–67)49 (30–67)
HRT, n (%)17 (21)21 (21)
Size: median (range), mm15 (4–50)15 (2–60)
Grade, n (%)
 I13 (16)16 (16)
 II24 (30)35 (35)
 III23 (29)30 (30)
 Othersa19 (25)19 (19)
Nodal status, n (%)
 Positive22 (28)22 (22)
 Negative/Unknown77 (72)78 (78)
Follow-up time, y
 0–84044
 >83956
ER+ cases
 All5485
 0–8 y2937
 >8 y2548
ER cases
 All2515
 0–8 y117
 >8 y148
  • aOthers – unknown, moderate, poor, well, not assessable.